InvestorsHub Logo
Followers 67
Posts 3747
Boards Moderated 0
Alias Born 08/30/2009

Re: PSea post# 148645

Wednesday, 02/24/2021 11:20:11 PM

Wednesday, February 24, 2021 11:20:11 PM

Post# of 232768
They recommended taking a second look at 75% enrollment, and to look at 42 day mortality at that time, however full enrollment was exceeded before that could occur. The second look is most unusual, and may have been recommended with a view to stop the trial for efficacy and petition for EUA.

Additionally, FDA granted EIND’s and OLE of the trial immediately after full enrollment. C’mon, those tea leaves are spelling in out explicitly for those who choose to look.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News